The Latest Breaking News on Pharma

JCVI says mRNA vaccines such as the Pfizer and Moderna jabs are the most effective for UK booster programme

The biotech industry is expected to see solid growth in the long term due to rising healthcare spending, breakthrough developments, and an aging population. Given the industry’s solid growth prospects and non-cyclical nature, it could be wise to invest in fundamentally strong biotech stocks Gilead Sciences (GILD), Biogen (BIIB), Jazz…

Avicanna (OTCQX: AVCNF), a biopharmaceutical company focused on cannabinoid-based products, released its Q2 2022 highlights:

Albert Bourla has already received four doses of the Pfizer-BioNTech vaccine

Analysis: a bivalent vaccine has been approved and research is being carried out into possible pan-coronavirus vaccines

The top executive at Pfizer, a leading producer of COVID-19 vaccines, has tested positive for the virus and says he is experiencing very mild symptoms

The groundbreaking Moderna jabs, which target both the Omicron variant and the original strain of the killer virus, will be rolled out in a bid to avoid a winter NHS nightmare

Packaging and logistics firm has taken additional space next to its headquarters in Staffordshire

The U.K. has granted the world’s first approval for a COVID-19 vaccine targeting a variant in a bid to sharpen its response to an evolving coronavirus.